274 related articles for article (PubMed ID: 20972433)
1. The TLX1 oncogene drives aneuploidy in T cell transformation.
De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA
Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433
[TBL] [Abstract][Full Text] [Related]
2. TLX1-induced T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Ferrando AA
Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452
[TBL] [Abstract][Full Text] [Related]
3. TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.
Owens BM; Hawley TS; Spain LM; Kerkel KA; Hawley RG
Br J Haematol; 2006 Jan; 132(2):216-29. PubMed ID: 16398656
[TBL] [Abstract][Full Text] [Related]
4. The T-ALL paradox in cancer.
Hoang T; Hoang T
Nat Med; 2010 Nov; 16(11):1185-6. PubMed ID: 21052064
[No Abstract] [Full Text] [Related]
5. Loss of Ubr1 promotes aneuploidy and accelerates B-cell lymphomagenesis in TLX1/HOX11-transgenic mice.
Chen E; Kwon YT; Lim MS; Dubé ID; Hough MR
Oncogene; 2006 Sep; 25(42):5752-63. PubMed ID: 16862188
[TBL] [Abstract][Full Text] [Related]
6. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.
Della Gatta G; Palomero T; Perez-Garcia A; Ambesi-Impiombato A; Bansal M; Carpenter ZW; De Keersmaecker K; Sole X; Xu L; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Meijerink JP; Califano A; Ferrando AA
Nat Med; 2012 Feb; 18(3):436-40. PubMed ID: 22366949
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.
Durinck K; Van Loocke W; Van der Meulen J; Van de Walle I; Ongenaert M; Rondou P; Wallaert A; de Bock CE; Van Roy N; Poppe B; Cools J; Soulier J; Taghon T; Speleman F; Van Vlierberghe P
Leukemia; 2015 Dec; 29(12):2317-27. PubMed ID: 26108691
[TBL] [Abstract][Full Text] [Related]
8. Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma.
Rakowski LA; Lehotzky EA; Chiang MY
PLoS One; 2011 Feb; 6(2):e16761. PubMed ID: 21326611
[TBL] [Abstract][Full Text] [Related]
9. PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia.
Kleppe M; Soulier J; Asnafi V; Mentens N; Hornakova T; Knoops L; Constantinescu S; Sigaux F; Meijerink JP; Vandenberghe P; Tartaglia M; Foa R; Macintyre E; Haferlach T; Cools J
Blood; 2011 Jun; 117(26):7090-8. PubMed ID: 21551237
[TBL] [Abstract][Full Text] [Related]
10. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal.
McCormack MP; Young LF; Vasudevan S; de Graaf CA; Codrington R; Rabbitts TH; Jane SM; Curtis DJ
Science; 2010 Feb; 327(5967):879-83. PubMed ID: 20093438
[TBL] [Abstract][Full Text] [Related]
11. TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.
Riz I; Hawley TS; Luu TV; Lee NH; Hawley RG
Mol Cancer; 2010 Jul; 9():181. PubMed ID: 20618946
[TBL] [Abstract][Full Text] [Related]
12. The DN2 Myeloid-T (DN2mt) Progenitor is a Target Cell for Leukemic Transformation by the TLX1 Oncogene.
Zweier-Renn LA; Riz I; Hawley TS; Hawley RG
J Bone Marrow Res; 2013 Feb; 1():. PubMed ID: 25309961
[TBL] [Abstract][Full Text] [Related]
13. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
Ehrlich LA; Yang-Iott K; Bassing CH
Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
[TBL] [Abstract][Full Text] [Related]
14. MEIS proteins as partners of the TLX1/HOX11 oncoprotein.
Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM
Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479
[TBL] [Abstract][Full Text] [Related]
15. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
Vanden Bempt M; Demeyer S; Broux M; De Bie J; Bornschein S; Mentens N; Vandepoel R; Geerdens E; Radaelli E; Bornhauser BC; Kulozik AE; Meijerink JP; Bourquin JP; de Bock CE; Cools J
Cancer Cell; 2018 Aug; 34(2):271-285.e7. PubMed ID: 30107177
[TBL] [Abstract][Full Text] [Related]
16. Ectopic TLX1 expression accelerates malignancies in mice deficient in DNA-PK.
Krutikov K; Zheng Y; Chesney A; Huang X; Vaags AK; Evdokimova V; Hough MR; Chen E
PLoS One; 2014; 9(2):e89649. PubMed ID: 24586935
[TBL] [Abstract][Full Text] [Related]
17. Novel insights on TLX1 function in T-ALL pave the way towards differentiation therapy.
De Keersmaecker K
Haematologica; 2012 Jun; 97(6):795. PubMed ID: 22665526
[No Abstract] [Full Text] [Related]
18. Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.
Riz I; Hawley TS; Johnston H; Hawley RG
Br J Haematol; 2009 Apr; 145(1):140-3. PubMed ID: 19133982
[No Abstract] [Full Text] [Related]
19. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
20. PHF6 mutations in T-cell acute lymphoblastic leukemia.
Van Vlierberghe P; Palomero T; Khiabanian H; Van der Meulen J; Castillo M; Van Roy N; De Moerloose B; Philippé J; González-García S; Toribio ML; Taghon T; Zuurbier L; Cauwelier B; Harrison CJ; Schwab C; Pisecker M; Strehl S; Langerak AW; Gecz J; Sonneveld E; Pieters R; Paietta E; Rowe JM; Wiernik PH; Benoit Y; Soulier J; Poppe B; Yao X; Cordon-Cardo C; Meijerink J; Rabadan R; Speleman F; Ferrando A
Nat Genet; 2010 Apr; 42(4):338-42. PubMed ID: 20228800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
